Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1961 1
1962 2
1963 4
1964 4
1965 2
1966 1
1967 6
1968 7
1969 3
1970 3
1971 2
1972 3
1975 4
1976 2
1977 10
1978 6
1979 10
1980 7
1981 7
1982 7
1983 6
1984 6
1985 8
1986 4
1987 3
1988 3
1989 1
1990 1
1991 3
1992 5
1993 2
1994 3
1995 5
1996 1
1997 3
1998 7
1999 4
2000 7
2001 5
2002 10
2003 5
2004 14
2005 28
2006 29
2007 28
2008 27
2009 26
2010 24
2011 27
2012 30
2013 28
2014 27
2015 34
2016 30
2017 32
2018 16
2019 16
2020 17
2021 18
2022 15
2023 18
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

588 results

Results by year

Filters applied: . Clear all
Page 1
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.
John T, Sakai H, Ikeda S, Cheng Y, Kasahara K, Sato Y, Nakahara Y, Takeda M, Kaneda H, Zhang H, Maemondo M, Minato K, Hisada T, Misumi Y, Satouchi M, Hotta K, Li A, Oukessou A, Lu S. John T, et al. Among authors: kaneda h. Int J Clin Oncol. 2022 Apr;27(4):695-706. doi: 10.1007/s10147-022-02120-0. Epub 2022 Feb 19. Int J Clin Oncol. 2022. PMID: 35182247 Free PMC article. Clinical Trial.
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.
Takahashi T, Yamanaka T, Seto T, Harada H, Nokihara H, Saka H, Nishio M, Kaneda H, Takayama K, Ishimoto O, Takeda K, Yoshioka H, Tachihara M, Sakai H, Goto K, Yamamoto N. Takahashi T, et al. Among authors: kaneda h. Lancet Oncol. 2017 May;18(5):663-671. doi: 10.1016/S1470-2045(17)30230-9. Epub 2017 Mar 23. Lancet Oncol. 2017. PMID: 28343976 Clinical Trial.
Malformations of dorsal induction.
Kanekar S, Kaneda H, Shively A. Kanekar S, et al. Among authors: kaneda h. Semin Ultrasound CT MR. 2011 Jun;32(3):189-99. doi: 10.1053/j.sult.2011.02.009. Semin Ultrasound CT MR. 2011. PMID: 21596275 Review.
Regenerative medicine in critical limb ischemia.
Ohno T, Kaneda H, Nagai Y, Fukushima M. Ohno T, et al. Among authors: kaneda h. J Atheroscler Thromb. 2012;19(10):883-9. doi: 10.5551/jat.12906. Epub 2012 Jun 8. J Atheroscler Thromb. 2012. PMID: 22785564 Free article. Review.
Nonpuerperal mastitis and subareolar abscess of the breast.
Kasales CJ, Han B, Smith JS Jr, Chetlen AL, Kaneda HJ, Shereef S. Kasales CJ, et al. Among authors: kaneda hj. AJR Am J Roentgenol. 2014 Feb;202(2):W133-9. doi: 10.2214/AJR.13.10551. AJR Am J Roentgenol. 2014. PMID: 24450694 Review.
Malformations of ventral induction.
Kanekar S, Shively A, Kaneda H. Kanekar S, et al. Among authors: kaneda h. Semin Ultrasound CT MR. 2011 Jun;32(3):200-10. doi: 10.1053/j.sult.2011.02.012. Semin Ultrasound CT MR. 2011. PMID: 21596276 Review. No abstract available.
B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
Yonesaka K, Haratani K, Takamura S, Sakai H, Kato R, Takegawa N, Takahama T, Tanaka K, Hayashi H, Takeda M, Kato S, Maenishi O, Sakai K, Chiba Y, Okabe T, Kudo K, Hasegawa Y, Kaneda H, Yamato M, Hirotani K, Miyazawa M, Nishio K, Nakagawa K. Yonesaka K, et al. Among authors: kaneda h. Clin Cancer Res. 2018 Jun 1;24(11):2653-2664. doi: 10.1158/1078-0432.CCR-17-2852. Epub 2018 Mar 12. Clin Cancer Res. 2018. PMID: 29530936
Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE).
Higashiyama T, Sugino K, Hara H, Ito KI, Nakashima N, Onoda N, Tori M, Katoh H, Kiyota N, Ota I, Suganuma N, Hibi Y, Nemoto T, Takahashi S, Yane K, Ioji T, Kojima S, Kaneda H, Sugitani I, Tahara M. Higashiyama T, et al. Among authors: kaneda h. Eur J Cancer. 2022 Sep;173:210-218. doi: 10.1016/j.ejca.2022.06.044. Epub 2022 Aug 3. Eur J Cancer. 2022. PMID: 35932627 Clinical Trial.
588 results